Related references
Note: Only part of the references are listed.2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
CHEST (2016)
Predictive Value of Serial High-Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Pathogenesis of systemic sclerosis
Debendra Pattanaik et al.
FRONTIERS IN IMMUNOLOGY (2015)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mortality and survival in systemic sclerosis: Systematic review and meta-analysis
Manuel Rubio-Rivas et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Interstitial Lung Disease in Systemic Sclerosis
Athol U. Wells et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Endothelial GATA-6 Deficiency Promotes Pulmonary Arterial Hypertension
Angela Ghatnekar et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Angelo De Lauretis et al.
JOURNAL OF RHEUMATOLOGY (2013)
Survival and Causes of Death in an Unselected, and Complete Cohort of Norwegian Patients with Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
JOURNAL OF RHEUMATOLOGY (2013)
Definitions and Diagnosis of Pulmonary Hypertension
Marius M. Hoeper et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations
Philip H. Quanjer et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Type I immune response cytokine-chemokine cascade is associated with pulmonary arterial hypertension
David J. Ross et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis
Vyacheslav Palchevskiy et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
C. J. Zappala et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Fleischner Society: Glossary of terms tor thoracic imaging
David M. Hansell et al.
RADIOLOGY (2008)
Autoantibodies in systemic sclerosis
VD Steen
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Up regulated expression of fractalkine/CX(3)CL1 and CX(3)CR1 in patients with systemic sclerosis
M Hasegawa et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
The role of the Th2CC chemokine ligand CCL17 in pulmonary fibrosis
JA Belperio et al.
JOURNAL OF IMMUNOLOGY (2004)
Share Paper
